{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:24:38Z","timestamp":1794936278476,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0522800\/2024ZD0522806"],"award-info":[{"award-number":["2024ZD0522800\/2024ZD0522806"]}]},{"name":"key project of Hubei provincial Natural Science Foundation","award":["2023BCB014"],"award-info":[{"award-number":["2023BCB014"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82172034, No. 82472058"],"award-info":[{"award-number":["No. 82172034, No. 82472058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01382-5","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:46:40Z","timestamp":1774608400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter study"],"prefix":"10.1038","volume":"10","author":[{"given":"Yusheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Long","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"1382_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1382_CR2","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","volume":"5","author":"WSME Theelen","year":"2019","unstructured":"Theelen, W. S. M. E. et al. Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non-small cell lung cancer: Results of the PEMBRO-RT phase 2 randomized clinical trial. JAMA Oncol. 5, 1276\u20131282 (2019).","journal-title":"JAMA Oncol."},{"key":"1382_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40425-019-0656-3","volume":"7","author":"G Guo","year":"2019","unstructured":"Guo, G. et al. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes. J. Immunother. Cancer 7, 179 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1382_CR4","doi-asserted-by":"publisher","unstructured":"Nakao S. et al. Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade. Sci Transl Med. 12https:\/\/doi.org\/10.1126\/scitranslmed.aax7992 (2020).","DOI":"10.1126\/scitranslmed.aax7992"},{"key":"1382_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.01.002","volume":"65","author":"MM Wattenberg","year":"2020","unstructured":"Wattenberg, M. M. & Beatty, G. L. Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle. Semin Cancer Biol. 65, 38\u201350 (2020).","journal-title":"Semin Cancer Biol."},{"key":"1382_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamaoncol.2024.1120","volume":"10","author":"TL Chaunzwa","year":"2024","unstructured":"Chaunzwa, T. L. et al. Body composition in advanced non-small cell lung cancer treated with immunotherapy. JAMA Oncol. 10, 773\u2013783 (2024).","journal-title":"JAMA Oncol."},{"key":"1382_CR7","doi-asserted-by":"publisher","first-page":"e2115274","DOI":"10.1001\/jamanetworkopen.2021.15274","volume":"4","author":"CA Fleming","year":"2021","unstructured":"Fleming, C. A. et al. Body composition, inflammation, and 5-year outcomes in colon cancer. JAMA Netw. Open 4, e2115274 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1382_CR8","doi-asserted-by":"publisher","first-page":"e203336","DOI":"10.1001\/jamasurg.2020.3336","volume":"155","author":"G Berardi","year":"2020","unstructured":"Berardi, G. et al. Association of sarcopenia and body composition with short-term outcomes after liver resection for malignant tumors. JAMA Surg. 155, e203336 (2020).","journal-title":"JAMA Surg."},{"key":"1382_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41586-024-07529-3","volume":"630","author":"JE Bader","year":"2024","unstructured":"Bader, J. E. et al. Obesity induces PD-1 on macrophages to suppress anti-tumour immunity. Nature. 630, 968\u2013975 (2024).","journal-title":"Nature"},{"key":"1382_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat. Med. 25, 141\u2013151 (2019).","journal-title":"Nat. Med."},{"key":"1382_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00408-020-00388-5","volume":"198","author":"L Gazourian","year":"2020","unstructured":"Gazourian, L. et al. Quantitative pectoralis muscle area is associated with the development of lung cancer in a large lung cancer screening cohort. Lung. 198, 847\u2013853 (2020).","journal-title":"Lung"},{"key":"1382_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03901-5","volume":"21","author":"SS Cury","year":"2023","unstructured":"Cury, S. S. et al. Low muscle mass in lung cancer is associated with an inflammatory and immunosuppressive tumor microenvironment. J. Transl. Med 21, 116 (2023).","journal-title":"J. Transl. Med"},{"key":"1382_CR13","doi-asserted-by":"publisher","unstructured":"Cortellini A. et al. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. J. Immunother Cancer. 10https:\/\/doi.org\/10.1136\/jitc-2021-004374 (2022).","DOI":"10.1136\/jitc-2021-004374"},{"key":"1382_CR14","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1007\/s00330-019-06630-w","volume":"30","author":"P Blanc-Durand","year":"2020","unstructured":"Blanc-Durand, P. et al. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer. Eur. Radio. 30, 3528\u20133537 (2020).","journal-title":"Eur. Radio."},{"key":"1382_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/jcsm.12755","volume":"12","author":"Y Takenaka","year":"2021","unstructured":"Takenaka, Y., Oya, R., Takemoto, N. & Inohara, H. Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis. J. Cachexia Sarcopenia Muscle 12, 1122\u20131135 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1382_CR16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","volume":"23","author":"JH Stern","year":"2016","unstructured":"Stern, J. H., Rutkowski, J. M. & Scherer, P. E. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 23, 770\u2013784 (2016).","journal-title":"Cell Metab."},{"key":"1382_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101143","volume":"63","author":"D Lettieri-Barbato","year":"2020","unstructured":"Lettieri-Barbato, D. & Aquilano, K. Aging and immunometabolic adaptations to thermogenesis. Ageing Res. Rev. 63, 101143 (2020).","journal-title":"Ageing Res. Rev."},{"key":"1382_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1695874","volume":"2019","author":"SI Bekkelund","year":"2019","unstructured":"Bekkelund, S. I. & Jorde, R. Alanine aminotransferase and body composition in obese men and women. Dis. Markers. 2019, 1695874 (2019).","journal-title":"Dis. Markers"},{"key":"1382_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","volume":"6","author":"G Kichenadasse","year":"2020","unstructured":"Kichenadasse, G. et al. Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer. JAMA Oncol. 6, 512\u2013518 (2020).","journal-title":"JAMA Oncol."},{"key":"1382_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/er.2010-0030","volume":"32","author":"J Park","year":"2011","unstructured":"Park, J., Euhus, D. M. & Scherer, P. E. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr. Rev. 32, 550\u2013570 (2011).","journal-title":"Endocr. Rev."},{"key":"1382_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937406","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang, M., Wei, T., Zhang, X. & Guo, D. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy. Front Immunol. 13, 937406 (2022).","journal-title":"Front Immunol."},{"key":"1382_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41573-022-00493-5","volume":"21","author":"TK Kim","year":"2022","unstructured":"Kim, T. K., Vandsemb, E. N., Herbst, R. S. & Chen, L. Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities. Nat. Rev. Drug Discov. 21, 529\u2013540 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1382_CR23","doi-asserted-by":"publisher","unstructured":"Nirschl C. J. et al. IFN\u03b3-dependent tissue-immune homeostasis is co-opted in the tumor microenvironment. Cell. 170https:\/\/doi.org\/10.1016\/j.cell.2017.06.016 (2017).","DOI":"10.1016\/j.cell.2017.06.016"},{"key":"1382_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jtho.2023.03.012","volume":"18","author":"D Sun","year":"2023","unstructured":"Sun, D. et al. Classification of tumor immune microenvironment according to programmed death-ligand 1 expression and immune infiltration predicts response to immunotherapy plus chemotherapy in advanced patients with NSCLC. J. Thorac. Oncol. 18, 869\u2013881 (2023).","journal-title":"J. Thorac. Oncol."},{"key":"1382_CR25","doi-asserted-by":"publisher","unstructured":"Huang Z. et al. Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. Proc. Natl. Acad. Sci. USA. 118https:\/\/doi.org\/10.1073\/pnas.2023216118 (2021).","DOI":"10.1073\/pnas.2023216118"},{"key":"1382_CR26","doi-asserted-by":"publisher","unstructured":"Oliva M. et al. The impact of sex on gene expression across human tissues. Science. 369https:\/\/doi.org\/10.1126\/science.aba3066 (2020).","DOI":"10.1126\/science.aba3066"},{"key":"1382_CR27","first-page":"291","volume":"20","author":"P Bj\u00f6rntorp","year":"1996","unstructured":"Bj\u00f6rntorp, P. The regulation of adipose tissue distribution in humans. Int J. Obes. Relat. Metab. Disord. 20, 291\u2013302 (1996).","journal-title":"Int J. Obes. Relat. Metab. Disord."},{"key":"1382_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/humupd\/dmp005","volume":"15","author":"G Fanciulli","year":"2009","unstructured":"Fanciulli, G., Delitala, A. & Delitala, G. Growth hormone, menopause and ageing: no definite evidence for \u2018rejuvenation\u2019 with growth hormone. Hum. Reprod. Update 15, 341\u2013358 (2009).","journal-title":"Hum. Reprod. Update"},{"key":"1382_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.adx4381","volume":"389","author":"S Sharma","year":"2025","unstructured":"Sharma, S., Gibbons, A. & Saphire, E. O. Sex differences in tissue-specific immunity and immunology. Science 389, 599\u2013603 (2025).","journal-title":"Science"},{"key":"1382_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41568-024-00680-z","volume":"24","author":"T Xiao","year":"2024","unstructured":"Xiao, T. et al. Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications. Nat. Rev. Cancer 24, 338\u2013355 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"1382_CR31","doi-asserted-by":"publisher","unstructured":"Young A. C. et al. Impact of body composition on outcomes from anti-PD1 +\/- anti-CTLA-4 treatment in melanoma. J Immunother Cancer. 8https:\/\/doi.org\/10.1136\/jitc-2020-000821 (2020).","DOI":"10.1136\/jitc-2020-000821"},{"key":"1382_CR32","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Banoy N. et al. Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer. J Clin Invest. 134https:\/\/doi.org\/10.1172\/JCI180516 (2024).","DOI":"10.1172\/JCI180516"},{"key":"1382_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13758","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu, J. et al. Paradoxical effect of myosteatosis on the immune checkpoint inhibitor response in metastatic renal cell carcinoma. J. Cachexia Sarcopenia Muscle 16, e13758 (2025).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1382_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. M. Transparent Reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. Ann. Intern Med. 162, 55\u201363 (2015).","journal-title":"Ann. Intern Med."},{"key":"1382_CR35","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.230024","volume":"5","author":"J Wasserthal","year":"2023","unstructured":"Wasserthal, J. et al. TotalSegmentator: Robust segmentation of 104 anatomic structures in CT images. Radio. Artif. Intell. 5, e230024 (2023).","journal-title":"Radio. Artif. Intell."},{"key":"1382_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70398","volume":"6","author":"B Gong","year":"2025","unstructured":"Gong, B. et al. A combined model based on bone mineral density for noninvasive prediction of prognosis in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A multicenter retrospective study. MedComm (2020) 6, e70398 (2025).","journal-title":"MedComm (2020)"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01382-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01382-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01382-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:13:34Z","timestamp":1779232414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01382-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1382"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01382-5","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}